Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSoftcat Regulatory News (SCT)

Share Price Information for Softcat (SCT)

Share Price is delayed by 15 minutes
Get Live Data
1,872.00    -8.00 (-0.43%)
Bid:
1,864.00
Ask:
1,867.00
Spread: 3.00 (0.161%)
Market Cap: £3.67b
SCT Live PriceLast checked at - London Stock Exchange

Intraday Softcat Share Chart

Year End Trading Update

28 Aug 2025 07:00

RNS Number : 9365W
Softcat PLC
28 August 2025
 

28 August 2025

Softcat plc

Year End Trading Update

 

Softcat plc ("Softcat", or the "Group"), a leading UK provider of IT infrastructure technology and services, today publishes a trading update (unaudited) for the financial year ended 31 July 2025.

 

Following the update provided on 28 May, the Group continued to trade well during the fourth quarter, supported by further conversion of larger solutions projects. As a result, the Board now expects to deliver high-teens growth in full year gross profit and mid-teens growth in operating profit1. The Group also remains highly cash generative, with FY2025 cash conversion2 expected to be towards the top end of our guided range of 85%-95%.

 

Looking ahead, Softcat remains well positioned to deliver further growth. Excluding the significant incremental contribution from large projects in FY2025, the Board expects to deliver low double-digit gross profit growth and high single-digit operating profit growth in FY20263. Including the significant incremental contribution from large deals in the comparative period, this translates to reported rates of high single-digit gross profit growth and low single-digit growth in operating profit.

 

Softcat's FY2025 preliminary results are scheduled for release on 22 October 2025.

 

 

1 Full year operating profit adjusted to remove non-underlying items, including acquisition-related expenses such as the fair value of deferred contingent consideration, and implementation costs of the new sales system. FY2025 guidance remains on a consistent basis with that provided in previous statements.

2 Cash conversion adjusted to remove the impact of non-underlying items and acquisition-related cash flows.

3Operating profit excluding the significant incremental contribution from large deals in FY2025 is c.£170m.

 

For further information, please contact:

Softcat plc

Graham Charlton, Chief Executive Officer + 44 (0)1628 403 610

Katy Mecklenburgh, Chief Financial Officer

Michael Watts, Head of Investor Relations

 

Media Enquiries ‐ FTI Consulting LLP

Ed Bridges/Matt Dixon + 44 (0)20 3727 1000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFLRTSIDFIE
Date   Source Headline
1st Jun 20263:37 pmRNSAdmission to Trading
1st Jun 20263:32 pmRNSTotal Voting Rights
22nd May 20267:00 amRNSQ3 2026 Trading Update
8th May 20263:39 pmRNSDirector/PDMR Shareholding
7th May 20263:50 pmRNSHolding(s) in Company
6th May 202611:00 amRNSHolding(s) in Company
5th May 20262:00 pmRNSHolding(s) in Company
1st May 20269:42 amRNSTotal Voting Rights
1st May 20269:39 amRNSAdmission to Trading
30th Apr 202610:00 amRNSHolding(s) in Company
29th Apr 202612:39 pmRNSDirector/PDMR Shareholding
29th Apr 20269:25 amRNSHolding(s) in Company
27th Apr 202611:06 amRNSHolding(s) in Company
23rd Apr 20262:55 pmRNSDirector/PDMR Shareholding
14th Apr 20262:59 pmRNSHolding(s) in Company
13th Apr 20269:02 amRNSHolding(s) in Company
9th Apr 20264:05 pmRNSDirector/PDMR Shareholding
1st Apr 202612:26 pmRNSAdmission to Trading
1st Apr 202611:56 amRNSTotal Voting Rights
18th Mar 20267:00 amRNSHalf-year Report
11th Mar 202611:03 amRNSDirector/PDMR Shareholding
11th Mar 202611:03 amRNSDirector/PDMR Shareholding
2nd Mar 20269:51 amRNSTotal Voting Rights
27th Feb 20267:00 amRNSNotice of Results
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20265:44 pmRNSTransaction in Own Shares
12th Feb 20266:09 pmRNSTransaction in Own Shares
11th Feb 20265:32 pmRNSTransaction in Own Shares
10th Feb 20265:44 pmRNSTransaction in Own Shares
10th Feb 20262:32 pmRNSDirector/PDMR Shareholding
9th Feb 20265:52 pmRNSTransaction in Own Shares
6th Feb 20265:52 pmRNSTransaction in Own Shares
5th Feb 20265:49 pmRNSTransaction in Own Shares
4th Feb 20266:01 pmRNSTransaction in Own Shares
3rd Feb 20265:49 pmRNSTransaction in Own Shares
2nd Feb 20265:49 pmRNSTransaction in Own Shares
2nd Feb 20264:06 pmRNSTotal Voting Rights
30th Jan 20265:33 pmRNSTransaction in Own Shares
29th Jan 20265:47 pmRNSTransaction in Own Shares
28th Jan 20265:37 pmRNSTransaction in Own Shares
27th Jan 20265:26 pmRNSTransaction in Own Shares
26th Jan 20265:38 pmRNSTransaction in Own Shares
23rd Jan 20265:29 pmRNSTransaction in Own Shares
22nd Jan 20265:30 pmRNSTransaction in Own Shares
21st Jan 20265:12 pmRNSTransaction in Own Shares
20th Jan 20265:42 pmRNSTransaction in Own Shares
19th Jan 20265:33 pmRNSTransaction in Own Shares
16th Jan 20265:16 pmRNSTransaction in Own Shares
15th Jan 20265:29 pmRNSTransaction in Own Shares
14th Jan 20265:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.